The Cell Therapy and Regenerative Medicine Program (CellReGen) at the University of Utah provides hematopoietic stem and progenitor cells to the Huntsman Cancer Institute Blood and Marrow Transplant Program, Primary Children's Hospital and LDS Hospital in support of:

  • Autologous/Allogeneic PBSC Processing, Cryopreservation/Infusion and Storage
  • Autologous/Allogeneic Bone Marrow Processing, Cryopreservation/Infusion and Storage
  • Cord Blood Processing and Infusion
  • Flow Cytometry Analysis for HPC Products
  • CD34+ Selection
  • HPC Apheresis, MNC Apheresis
  • Cellular Immunotherapies
  • Commercialized & Clinical Trial CAR-T Therapy
  • Cytotoxic T Lymphocyte Therapy

Therapeutic Apheresis

  • Platelet Depletion
  • Red Blood Cell Exchange
  • White Blood Cell Depletion